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The open reading frame (ORF) III product (PIII) of the pararetrovirus cauliflower mosaic virus (CaMV) has nucleic
acid-binding properties in vitro, but its biological role is not yet determined. ORF III is closely linked to ORF II and overlaps
ORF IV out of frame in the CaMV genome. A new CaMV-derived vector (CaD) devoid of ORF III and containing unique
restriction sites between ORFs II and IV was designed. Introduction of the wild-type CaMV ORF III into CaD results in a clone
(Ca3) infectious in turnip plants. Truncated or point-mutated versions of ORF III were then inserted into CaD and tested in
vivo. Inoculation of the different mutants into turnip revealed that the four C-terminal amino acid residues of PIII are
dispensable for infectivity as well as an internal domain (amino acids 61 to 80). Taken together the results show that PIII
possesses a functional two-domain organization. Moreover, the CaMV PIII function(s) cannot be replaced either by the PIII
protein of another caulimovirus, the figwort mosaic virus, or by the P2 protein of the cacao swollen shoot badnavirus, a
member of the second plant pararetrovirus group. © 1998 Academic Press
Cauliflower mosaic virus (CaMV) is a plant pararetro-
virus, the type member of the caulimovirus group (for
reviews, Jacquot et al., 1997; Rothnie et al., 1994). The
CaMV particle is an icosahedron with a diameter of 52.3
nm and a triangulation T 5 7 (Cheng et al., 1992). It
contains a circular double-stranded DNA molecule of
about 8.0 kbp, interrupted by site-specific discontinuities
resulting from its replication by reverse transcription. Six
major open reading frames (ORFs) are located on the
plus strand of viral DNA (Fig. 1). The first five ORFs are
separated (I/II and II/III), or overlap (III/IV and IV/V) by a
few nucleotides. ORFs I to V are expressed from the
pregenomic polycistronic 35 S RNA which is also used
as template for reverse transcription. ORF VI is translated
from the monocistronic 19 S RNA. These two transcripts
start at distinct sites but share the same 39 end. Most of
the viral functions of the encoded proteins are known
(Fig. 1). ORF I codes for a protein involved in cell-to-cell
movement (Thomas et al., 1993) and ORF II for an aphid
transmission factor involved in plant-to-plant transmis-
sion of the virus via its insect vector, Myzus persicae
(Woolston et al., 1987). The coat protein is synthesized
from ORF IV (Daubert et al., 1982). The ORF V product is
a bifunctional protein which presents at its N-terminus a
proteinase domain (Torruella et al., 1989) followed by the
reverse transcriptase domain (Takatsuji et al., 1986). ORF
VI encodes a protein which is the structural component
of inclusion bodies and plays a role in translational
transactivation (Bonneville et al., 1989), host range, and
symptomatology (Schoelz and Shepherd, 1988). All these
ORFs, except ORF II, are essential for the viral cycle
since most of their modifications by deletion or insertion
of sequences are lethal for the virus whether or not they
cause a frameshift mutation (Choe et al., 1985; Daubert
et al., 1983; Dixon et al., 1983; Lebeurier et al., 1982). An
in-frame insertion of 12 nt in ORF VI was shown not to
destroy infectivity (Daubert et al., 1983).
Finally, ORF III, located between nucleotides 1830 and
2219 (Franck et al., 1980), codes for a small basic protein
of 15 kDa (PIII, 129 amino acids long) whose function is
unknown. This 15-kDa protein is cleaved at a site near its
C-terminus by a cysteine proteinase (Dautel et al., 1994)
to produce an 11-kDa form (Giband et al., 1986). PIII
protein is known for its sequence-nonspecific nucleic
acid binding property due to the presence of a C-terminal
domain rich in basic amino acids (arginine and lysine),
hydrophobic amino acids (tryptophan, tyrosine, and phe-
nylalanine) and prolines; the same amino acids are
found at the C-terminus of other caulimovirus ORF III
products [for example, figwort mosaic virus (FMV)], of
badnavirus ORF 2 products [cacao swollen shoot virus
(CSSV) and rice tungro bacilliform virus (RTBV)], and of
histone-like proteins (Jacquot et al., 1996; Mougeot et al.,
1993). Previous studies on CaMV have shown that the
ORF III sequence cannot be modified except for a short
insertion of 12 bp at position 2040 (Melcher et al., 1986).
Indeed, all other modifications of this ORF abolish the
infectivity of the genome, including mutations to cause
an in-frame deletion of amino acids S34 to G107 (Lebeu-
rier et al., 1982), the removal of 51 or 17 C-terminal
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residues (Daubert et al., 1983; Dixon et al., 1983), or an
extension of 4 amino acids (Melcher et al., 1986).
In order to determine the importance of the CaMV PIII
protein in the viral cycle and its functional region(s), we
engineered a new infectious CaMV clone. Its use made
it possible to study the effect of PIII mutations on CaMV
infection in planta.
RESULTS
Designing a new CaMV genome
ORFs II and III are separated by 2 nucleotides,
whereas ORFs III and IV overlap each other out of frame
by 18 nucleotides in the CaMV Cabb-S genome. Such a
genomic organization makes it difficult to mutagenize
ORF III without modifying the N-terminal sequence of the
ORF IV encoded coat protein. Consequently, to study
CaMV PIII mutants in vivo, we constructed a new CaMV-
derived vector (CaD) in which ORF III was replaced by a
small linker containing three unique additional restriction
sites, SpeI, NotI, and ApaI (Fig. 2). As expected from
published results on mutated ORF III (Choe et al., 1985;
Daubert et al., 1983; Dixon et al., 1983; Lebeurier et al.,
1982; Melcher et al., 1986), CaD is unable to infect plants.
It was used to clone wild-type or mutated ORF III without
affecting the ORF IV sequence. The full-length ORF III
(390 bp) with a point mutation making the ORF IV initia-
tion codon located in ORF III inactive (ATG replaced by
CTG) was inserted into SpeI and ApaI sites of pCaD. In
the resulting pCa3 genome (Fig. 2), ORF III is separated
from ORF II by seven nucleotides (including the SpeI site)
and from ORF IV by six nucleotides (including the ApaI
site). The Ca3 genome was excised from pCa3 by SalI
digestion and tested for turnip infection. Characteristic
symptoms appeared on young leaves 15 to 25 days
postinoculation as also for plants infected with the wild-
type CaMV Cabb-S genome. After two passages on tur-
nip, the virus was purified and analyzed for its protein
and DNA content. Electrophoretic protein patterns ob-
served after Coomassie blue staining and immunodetec-
tion with antibodies raised against the coat protein did
not exhibit qualitative differences between Cabb-S and
Ca3. Moreover, PIII was immunodetected in extracts of
leaves infected with Ca3. Stability of the Ca3 genome in
the progeny was checked first by analyzing restriction
digests of its DNA. In particular, double digestion of Ca3
DNA by SpeI and ApaI yielded two fragments of 7.6 kbp
and 390 bp, the latter corresponding to the inserted ORF
III. This short fragment was absent in the Cabb-S DNA
digest. Finally, nucleotide sequencing confirmed the in-
tegrity of ORF III present in the Ca3 progeny. Therefore,
FIG. 1. Genome organization of CaMV. From left to right: circular viral
DNA with its discontinuities D1, D2, and D3 is represented in a linear
manner by a thin double line. The two major viral transcripts are
illustrated by thin arrows. Boxes represent open reading frames I to VI,
and functions of the corresponding proteins are listed.
FIG. 2. Genomic organization in the vicinity of ORF III of wild-type CaMV strain Cabb-S and of derived mutants CaD and Ca3. Boxes correspond
to ORFs II, III, and IV. Additional restriction sites are designated by underlined or shadowed nucleotide sequences. Start and stop codons are
indicated in bold. Arrowhead denotes point mutation inside ORF III inactiving ORF IV start codon. Top numbers are nucleotide positions in the Cabb-S
genome.
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pCaD can be used for mutagenesis experiments devoted
to the study of the CaMV PIII protein in the viral cycle.
Are the PIII amino acids involved in nucleic acid
binding important for CaMV infectivity?
The CaMV PIII C-terminus is involved in DNA binding
(Mougeot et al., 1993) and our recent work has shown
that PIII is also able to bind RNA (Jacquot et al., 1996).
Binding of either nucleic acid occurs in a sequence-
nonspecific manner. To determine whether the binding to
RNA also involves the C-terminus, we first introduced
different deletions in this region (Fig. 3). Analysis by
SDS–PAGE of the corresponding soluble proteins col-
lected after lysis and heat-treatment of induced recom-
binant bacteria is illustrated in Fig. 4A. These fractions
enriched in complete or truncated PIII protein were used
in equivalent amounts for binding to RNA as well as to
DNA. Indeed, the truncated proteins contained neither a
fused peptide at their N-terminus nor additional amino
acid(s) at their C-terminus, unlike those used by Mou-
geot et al. (1993) to study the binding to DNA. Deletion of
4 or 8 amino acids from the C-terminus (F129 to P126 or
F129 to P122, respectively) barely modifies the binding
capacity for either DNA (Fig. 4B, lanes 2 and 3) or RNA
(Fig. 4C, lanes 2 and 3), whereas the removal of 12 amino
acids (F129 to P118) significantly reduces binding (Figs. 4B
and 4C, lanes 4). PIII deleted of the last 18 amino acids
(F129 to P112) is no more able to interact with either type
of nucleic acid under our experimental conditions (Figs.
4B and 4C, lanes 5). These results indicate that the
region between residues P112 and A121 in the C-terminus
of PIII is part of the DNA and RNA interaction domain. To
determine whether this region is important for infectivity,
CaMV genomes with these PIII mutations were mechan-
ically inoculated to turnips. Only mutant pCa3D4 was
infectious (Table 1). The symptoms due to this mutant
appeared at the same rate as those of wild-type infec-
tions and did not differ from the latter. No symptoms
FIG. 3. Schematic representation of CaMV-modified ORFs III inserted into pCaD and features of the resulting proteins. Open boxes corresponding
to CaMV ORF II (left side) and ORF IV (right side) surround complete, deleted, or mutated ORF III. Thin broken lines represent inner in-frame deletions
of ORF III. Black ovals correspond to point mutations in ORF III. The restriction sites SpeI and ApaI surrounding CaMV ORF III are indicated. Deletions,
point mutations, or other modifications of PIII are listed for each construct.
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were observed with plants treated with the other mutated
genomes even 6 weeks after inoculation. The absence of
CaMV DNA in the asymptomatic plants was checked by
PCR. As mutant pCa3D8 is not infectious, it appears that
the region delimited by P122 and W125 is required for
infectivity. To determine the crucial deletion limit, recur-
rent deletions from W125 to P122 were performed (Fig. 3).
None of the corresponding mutants was infectious (Ta-
ble 1). Thus, the permissive deletion domain corre-
sponds to the last 4 amino acids 126PNQF129. To check
the importance of the C-terminal prolines in the function
of PIII, as suggested by Mougeot et al. (1993), CaMV PIII
proteins with single (P118, P122, or P126 replaced by A) or
double (W125 and P126 changed to R125 and A126) point
mutations were constructed. All these PIII mutant pro-
teins bind nucleic acids (Table 1). The corresponding
pCaD-derived plasmids were tested for their infectivity.
Single point mutations replacing either P118 or P122 abol-
ish systemic infection of plants (Table 1). However, a
single point mutation affecting P126 or a double point
mutation replacing P126 and W125 does not change the
infectivity of the recombinant clone (Table 1).
Infectivity of CaMV genomes containing deleted
or chimeric ORF III
The involvement of other parts of the CaMV PIII protein
in the infectious process was investigated by producing
recurrent deletions of 10 or 20 amino acids in PIII ex-
tending from the N-terminus to amino acid 110. After
insertion of these deleted ORF III versions into pCaD
(Fig. 3), the resulting clones were tested for their infec-
tivity. Only clone pCa61/80 is able to systemically infect
turnip (Table 1), indicating the functional importance of
the N-terminal region (amino acid residues 1 to 60) and
the C-terminal region (amino acid residues 81 to 125).
The latter composes a highly conserved sequence
among the caulimoviruses, comprising residues 93–118
in CaMV PIII (Fig. 5). We investigated whether such a
sequence is interchangeable. Chimeric ORFs III inserted
in pCaD and encoding fusion proteins between the C-
terminus of CaMV PIII (amino acids 91–129) and the first
90 amino acids of either CSSV P2 or FMV PIII were
tested in vivo for their ability to substitute for CaMV ORF
III: they were unable to complement the CaMV ORF III
viral function(s). The same was observed when complete
CSSV ORF 2 or FMV ORF III replaced CaMV ORF III
(Table 1). It should be mentioned that contrary to CaMV
PIII and CSSV P2, the FMV PIII protein binds only DNA
(not shown).
DISCUSSION
Several studies have shown that ORF III is indispens-
able for CaMV infectivity. To look for permissive modifi-
cations in the CaMV PIII protein, we constructed a
CaMV-derived vector (CaD) devoid of ORF III and con-
taining additional unique restriction sites (SpeI, NotI, and
ApaI) between ORFs II and IV. These sites made it pos-
sible to insert wild-type or mutated versions of ORF III
into CaD. The genomic organization of the Ca3 clone,
containing the wild-type CaMV ORF III inserted between
the SpeI and ApaI sites of CaD, differs from the genomic
organization of the wild-type CaMV. Indeed, caulimovirus
FIG. 4. Nucleic acid-binding assays of the CaMV complete and deleted PIII proteins. Proteins were fractionated by SDS–PAGE (A, B, and C). Each
lane contained proteins (1 mg) from heat-treated soluble fractions of E. coli BL21/DE3 (pLysS) transformed with pETCa3 (lanes 1), pETCa3D4 (lanes
2), pETCa3D8 (lanes 3), pETCa3D12 (lanes 4), or pETCa3D18 (lanes 5). Proteins were stained with Coomassie blue (A). After electrotransfer onto
nitrocellulose membranes, the proteins were incubated in the presence of 32P-labeled double-stranded DNA from CaMV (B) or 32P-labeled
single-stranded RNA from CSSV (C). The resulting DNA– and RNA–protein complexes were visualized by autoradiography. Arrowheads denote the
position of the complete CaMV PIII protein.
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ORFs II and III are separated by two nucleotides (CaMV
isolates Cabb-S, D/H, JI, and B29), are adjacent (FMV and
dahlia mosaic virus, DaMV), or overlap by three nucleo-
tides (carnation etched ring virus, CERV), whereas ORFs
III and IV overlap by 18, 12, or 3 nucleotides for FMV and
the above CaMV isolates, DaMV or CERV, respectively. In
the CaMV Ca3 genome, the distances between ORFs II
and III and ORFs III and IV are 7 and 6 nucleotides,
respectively. Ca3 inoculated to turnip is infectious. Con-
sequently, translation of the polycistronic RNA 35S ac-
cording to a ‘‘relay race’’ model (see Bonneville et al.,
1989) does not require an overall conserved genomic
organization as already shown for another viable mutant
containing a linker insertion between ORF IV and ORF V
(Schultze et al., 1990).
The results of the infection experiments with the C-
terminally deleted ORF III permitted us to conclude that
the last four amino acids of PIII (residues 126PNQF129) are
dispensable. Moreover, taking into account the fact that
longer deletions including W125 affect infectivity and that
replacement of P126 by A126 does not, W125 is assumed to
be the C-terminal limit of the functional core of the PIII
protein. Nevertheless, the pCa125W126P mutant in which
W125 and P126 are respectively replaced by R125 and A126
is still infectious. In this mutant, the substitution of the
W125 residue would be compensated by at least one of
the C-terminal NQF residues. The other PIII point muta-
tions tested, which correspond to replacement of either
P118 or P122 by alanine, led to abortive viral multiplication
in plants demonstrating the involvement of these pro-
lines in the function of PIII. However, at variance with
previous results (Mougeot et al., 1993), PIII118P is able to
bind nucleic acids as does wild-type PIII.
In the past, various studies on the relationship be-
tween the integrity of ORF III and CaMV infectivity were
performed. It was concluded that the ORF III sequence
cannot be modified (Daubert et al., 1983; Dixon et al.,
1983; Lebeurier et al., 1982) except for an in-frame inser-
tion of 12 nucleotides leading to the change of T72 to P72
and the contiguous addition of 4 amino acids in the PIII
protein (Melcher et al., 1986). We found that deletion of
the 4 C-terminal amino acids or the in-frame deletion of
20 amino acids extending from residues 61 to 80 (Ca61/80)
does not disturb virus multiplication. This suggests that
the functional structure of PIII is bipartite with two re-
gions linked by a nonfunctional domain corresponding at
least to amino acids 61 to 80. A similar organization has
already been described for other small basic viral pro-
teins such as the phage l-encoded Cro protein which
presents a C-terminal domain responsible for dimeriza-
TABLE 1
Nucleic Acid-Binding Capacity of Wild-Type and Mutated CaMV PIII
Proteins, and Infectivity of Corresponding CaMV-Derived Plasmids
Protein
Nucleic acid-
binding assaya
Corresponding CaMV-
derived plasmids Infectivityb,c
None pCaD 0/18
WT 111 pCa3 18/18
PIIID4 111 pCa3D4 18/18
PIIID8 11 pCa3D8 0/18
PIIID12 1 pCa3D12 0/18
PIIID18 2 pCa3D18 0/18
PIIID5 NT pCa3D5 0/18
PIIID6 NT pCa3D6 0/18
PIIID7 NT pCa3D7 0/18
PIII126P 111 pCa126P 14/18
PIII122P 111 pCa122P 0/18
PIII118P 111 pCa118P 0/18
PIII125W126P 111 pCa125W126P 18/18
PIII20 NT pCa20 0/18
PIII21/40 NT pCa21/40 0/18
PIII41/60 NT pCa41/60 0/18
PIII61/80 NT pCa61/80 18/18
PIII81/100 NT pCa81/100 0/18
PIII101/110 NT pCa101/110 0/18
PFMCa NT pFMCa 0/18
PCSCa NT pCSCa 0/18
CSSV P2 111 pCaA2 0/18
FMV PIII 111 pCaFM3 0/18
Note. WT, wild-type control.
a Relative evaluation of both DNA- and RNA-binding assays, except
for FMV PIII which only binds DNA. 111, Strong binding; 11, inter-
mediate binding; 1, low binding; 2, no binding. NT, not tested.
b Total infected plants from three independent experiments carried
out with six plants per assay.
c Development and type of symptoms were similar in mutant and
wild-type infections. CaMV DNA was detected by PCR in the leaves
developed after inoculation from the corresponding plants but not from
the asymptomatic plants.
FIG. 5. Sequence comparison between the C-termini of caulimovirus PIII proteins. CaMV, FMV, CERV, and DaMV PIII sequences are from Franck
et al. (1980), Richins et al. (1987), Hull et al. (1986), and P. Yot (unpublished data), respectively. Conserved sequences are highlighted by grey boxes.
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tion connected to an N-terminal domain implicated in
DNA binding (Harrison and Aggarwal, 1990). The C-
terminal region of the CaMV PIII delimited by amino
acids 81 and 125 possesses nucleic acid-binding activity
(ending at A121) and is involved in an unknown function
requiring W125, P118, and P122. Sequence comparison
between the caulimovirus ORF III products shows that
PIII has a highly conserved C-terminal domain (amino
acids 91 to 118) with a score of about 80% identity (Fig. 5)
and an N-terminal region (amino acids 1 to 90) which
presents only 28% identity (not illustrated). The recombi-
nant pFMCa genome which codes for a fusion protein
between the FMV PIII protein (amino acids 1 to 90) and
the CaMV PIII protein (amino acids 91 to 129) is not
infectious. These data reinforce the proposal for a bipar-
tite functional organization of the protein PIII and suggest
a relationship between either the two regions or the
amino-terminal region and another cellular or viral com-
ponent. Interaction with a viral product would explain
why pCaFM3 containing the entire FMV ORF III instead
of CaMV ORF III is not infectious.
On the basis of the permissive mutations and of the
functional regions determined through the use of CaMV
Ca3, an overall organization of the PIII protein can be
proposed (Fig. 6). It should be pointed out that 24 amino
acid residues (P61 to E80 and P126 to F129), corresponding
to about one-fifth of the PIII protein, are not essential for
viral infection whereas P118 and P122 are required for
pathogenicity of CaMV as well as W125 if the 3 C-terminal
amino acids are deleted.
MATERIALS AND METHODS
Cloning of different versions of the CaMV ORF III
in the pET-3a expression vector
Complete ORF III. Full-length DNA of CaMV Cabb-S
(Franck et al., 1980) was used as template for PCR
amplification of the ORF III region. PCR was performed
using the oligonucleotides 59 ACGTAAGTGCCcatatg-
GCTAATCTTAATCAGATC 39 (corresponding to CaMV nt
1830–1850, in bold, and to a NdeI site, in lower case
letters) as forward primer and 59 AGGGCTGTgctcagc-
CTAAAATTGATTCGGCCAGCC 39 (corresponding to
CaMV nt 2219–2199, in bold, and to a CelII site, in lower
case letters, and including the underlined point mutation
modifying the initiation codon of the overlapping ORF IV
without affecting ORF III translation) as reverse primer.
The PCR fragment was cloned into the NdeI and CelII
sites of the pET-3a vector as previously described (Jac-
quot et al., 1996), and the resulting plasmid pETCa3 was
transferred by electroporation into Escherichia coli BL21/
DE3(plysS) (Studier and Moffatt, 1986). Recombinants
selected in the presence of the appropriate antibiotics
allowed synthesis of the CaMV PIII protein without fusion
domains.
Deleted versions of ORF III. Similarly, other plasmids
were constructed to produce different PIII protein mu-
tants. Plasmids encoding PIII versions truncated at the
C-terminus were generated using the above forward
primer and one of the following reverse primers con-
taining a CelII site: 59 AGGGCTGTgctcagcCTACCAGC-
CTGCTGGAGCTTTGAA 39 (corresponding to CaMV nt
2204–2184, in bold, and including the underlined point
mutation modifying the initiation codon of ORF IV),
59AGGGCTGTgctcagcCTATCCTGCTGGAGCTTTGAAGGG 39
(corresponding to CaMV nt 2201–2181, in bold), 59 AGGGCT-
GTgctcagcCTATGCTGGAGCTTTGAAGGGCCA 39 (corre-
sponding to CaMV nt 2198–2178, in bold), 59 AGGGCTGTgct-
cagcCTATGGAGCTTTGAAGGGCCAGGT 39 (corresponding
to CaMV nt 2195–2175, in bold), 59 AGGGCTGTgctcagcCTA-
AGCTTTGAAGGGCCAGGTTAA 39 (corresponding to CaMV
nt 2192–2172, in bold), 59 AGGGCTGTgctcagcCTACCAGGTTA-
AAGCTTTAGGGTT 39 (corresponding to CaMV nt
2180–2160, in bold), 59 AGGGCTGTgctcagcCTAGTTTC-
CAGAGGATCCTAATTC 39 (corresponding to CaMV nt
2162–2142, in bold). The resulting plasmids were des-
ignated pETCa3D4, pETCa3D5, pETCa3D6, pETCa3D7,
pETCa3D8, pETCa3D12, and pETCa3D18 and allowed
the synthesis of proteins PIIID4, PIIID5, PIIID6, PIIID7,
PIIID8, PIIID12, and PIIID18, deleted of the 4, 5, 6, 7, 8,
12, and 18 C-terminal amino acids, respectively.
Point mutated versions of ORF III. Plasmids encoding
PIII proteins with one or two mutated residues were con-
structed using the above forward primer and one of the fol-
lowing reverse primers containing a CelII site: 59GCTTCCG-
CAGGCgctcagcCTAAAATTGATTTGCCCAGCCTGC 39 (cor-
responding to CaMV nt 2219–2196, in bold, and including the
three underlined point mutations, the third one modifying the
initiation codon of ORF IV and the two others leading to the
substitution of A126 for P126), 59 GCTTCCGCAGGcgctcagcCTA-
AAATTGATTCGGCCAGCCTGCTGCAGCTTTGAA 39 (corre-
sponding to CaMV nt 2219–2184, in bold, and including the two
FIG. 6. Schematic representation of the CaMV PIII protein. The hatched boxes correspond to dispensable PIII regions. The grey region represents
the highly conserved sequence between caulimoviruses. The nucleic acid-binding domain (BD) overlaps P112 and extends to A121. Nonpermissive
point mutations corresponding to P118, P122, and W125 are denoted.
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underlined point mutations, the first one modifying the initiation
codon of ORF IV and the second one allowing the replace-
ment of P122 by A122), 59 GCTTCCGCAGGCgctcagcCTAAAAT-
TGATTCGGCCAGCCTGCTGGAGCTTTGAATGCCCAG-
GTTAA 39 (corresponding to CaMV nt 2219–2172, in
bold, and including the three underlined point muta-
tions, the first one modifying the initiation codon of
ORF IV and the two others leading to the substitution
of A118 for P118), 59 GCTTCCGCAGGCgctcagcCTA-
AAATTGATTTGCCGAGCCTGC 39 (corresponding to
CaMV nt 2219–2196, in bold, and including the four
underlined point mutations, the fourth one modifying
the initiation codon of ORF IV and the three others
leading to the substitution of A126 for P126 and of R125
for W125). The resulting plasmids, pETCa126P,
pETCa122P, pETCa118P, and pETCa125W126P, allowed
the synthesis of proteins PIII126P, PIII122P, PIII118P, and
PIII125W126P, respectively (the original amino acids are
indicated in the one-letter code in the plasmids and
the corresponding proteins).
Other constructions. A plasmid encoding the FMV PIII
protein (pETFM3) was constructed by inserting into
pET-3a a fragment obtained by amplification of the FMV
DNA genome (Richins et al., 1987) in the presence of the
appropriate primer pair (nt 1472–1502 and nt 1741–1711).
Finally, pET-3a-derived plasmids were constructed with
fused ORFs between parts of CaMV ORF III and FMV
ORF III or CSSV ORF 2 in order to produce chimeric viral
proteins. Sequences encoding the first 90 amino acids of
either FMV ORF III (nt 1472–1741) (Richins et al., 1987) or
CSSV ORF 2 (nt 869–1138) (Hagen et al., 1993) were
ligated to the CaMV sequence (nt 2100–2219) encoding
the C-terminus of CaMV PIII (amino acids 90–129) using
the ‘‘mega-primer’’ PCR system (Sarkar and Sommer,
1990). The resulting fragments were cloned into the NdeI
and CelII sites of pET-3a, allowing the formation of the
pETFMCa and pETCSCa plasmids and the expression of
the PFMCa and PCSCa proteins, respectively.
All plasmid constructions were confirmed to be error-
free by sequencing using the dideoxy chain termination
method. Plasmid pETA2 was used to produce the CSSV
P2 protein (Jacquot et al., 1996).
Production of proteins and nucleic acid-binding
assays
Induction of protein synthesis by IPTG in E. coli BL21/
DE3(plysS) (Studier and Moffatt, 1986), partial purification
of proteins by heat-treatment (65°C for 15 min), and
nucleic acid-binding assays were performed as already
described (Jacquot et al., 1996). Probes used for DNA-
and RNA-binding tests correspond to 32P-labeled CaMV
DNA produced by random priming (Feinberg and Vo-
gelstein, 1983) and to 32P-labeled RNA obtained by in
vitro transcription (Greif et al., 1990) of a CSSV DNA
fragment (nt 3168–3666), respectively.
Recombinant CaMV DNA clones
CaMV DNA cloned into the SalI site of pBR 322
(pCabb-S) was used as template for PCR amplification of
the 39 terminal region of ORF II and the 59 terminal region
of ORF IV. Amplifications were performed using either the
primer pair 59 ACGTAAGTGCCctcgagCCAACTAAAG-
GAAAT 39 (corresponding to CaMV nt 1642–1662, in
bold, and including an XhoI site, in lower case letters) as
forward primer and 59 GGGCTGTGgcggccgcactagt-
TTTAGCCAATAATATTCTTTAAT 39 (corresponding to
CaMV nt 1829–1807, in bold, and to NotI and SpeI sites,
in lower case letters) as reverse primer, or 59 CGTAAGT-
GCCgcggccgcgggcccATGGCCGAATCAATTTTAGAC 39
(corresponding to CaMV nt 2201–2221, in bold, and
to NotI and ApaI sites, in lower case letters) as forward
primer and 59 AGGGCTGTGgttaacGCTTTTTCTCCAA-
TGA 39 (corresponding to CaMV nt 3099–3078, in bold,
and including an HpaI site, in lower case letters) as
reverse primer. The PCR fragments digested with XhoI
and HpaI as well as NotI were cloned into the unique
XhoI and HpaI sites of pCabb-S in a three-way ligation.
The resulting plasmid pCaD was used to insert the wild-
type ORF III into the SpeI and ApaI sites to produce the
pCa3 plasmid (Fig. 2). Each construct was transferred
into E. coli DH5a by electroporation.
The above pET-3a-derived plasmids pETCa3D4,
pETCa3D5, pETCa3D6, pETCa3D7, pETCa3D8, pETCa3D12,
pETCa3D18, pETCa126P, pETCa122P, pETCa118P, pETCa125-
W126P, pETFMCa, pETCSCa, pETA2, and pETFM3 were used
as template for PCR amplification of ORF III mutants with the
appropriate primer pairs including an SpeI site and an ApaI
site for the forward and the reverse primers, respectively. Each
PCR fragment was inserted into the SpeI and ApaI sites of
pCaD to produce pCa3D4, pCa3D5, pCa3D6, pCa3D7,
pCa3D8, pCa3D12, pCa3D18, pCa126P, pCa122P, pCa118P,
pCa125W126P, pFMCa, pCSCa, pCaA2, and pCaFM3, respec-
tively (Fig. 3).
Finally, recurrent deletions of ORF III were produced
by the PCR mega-primer system in order to make in-
frame deletions of amino acids 1 to 20, 21 to 40, 41 to 60,
61 to 80, 81 to 100, or 101 to 110. PCR fragments were
obtained using the appropriate primers including SpeI
and ApaI sites and were cloned into pCaD to produce
pCa20, pCa21/40, pCa41/60, pCa61/80, pCa81/100, and
pCa101/110, respectively. All plasmid constructions
were confirmed to be error-free by sequencing.
Host plant and infectivity assays
Turnip (Brassica rapa L. cv. ‘‘Just right’’) was grown at
22°C in a 16/8 h day/night cycle. Recombinant CaMV
DNA clones were amplified in E. coli DH5a, isolated by
alkaline–SDS lysis (Nucleobond AX, Macherey-Nagel)
and digested by SalI to excise the viral genome from the
prokaryotic vector. Mechanical inoculation was per-
formed with 1 mg of CaMV DNA construct on one leaf of
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plants at the four-leaf stage. Symptoms were observed
15 to 25 days postinoculation. Young leaves of infected
plants were analyzed by PCR amplification of CaMV ORF
III region (nt 1590–2450) using the appropriate primer
pair, and the PCR fragment was sequenced to analyze
the CaMV progeny.
Virus purification and analysis
CaMV was extracted and purified according to Hull et
al. (1986). Virion proteins were analyzed by SDS–PAGE
(Laemmli, 1970). They were visualized by Coomassie
blue staining or immunodetected using sera raised
against the 37-kDa coat protein. CaMV DNA was purified
using proteinase K, phenol extraction, and alcohol pre-
cipitation. It was digested by restriction endonucleases
and analyzed by electrophoresis in 1% agarose gel in
TBE buffer (100 mM Tris-borate, pH 8.3, 2 mM EDTA).
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